Healthy Living/WellnessFDA advisers give thumbs up to MannKind's inhaled insulin drug for diabetics The U.S. FDA panel of advisers okays insulin that can be inhaled rather than injected. This would be the third time that MannKind, its manufacturer, has sought approval from the FDA for its new drug called Afrezza.by Maryanne Moll
Healthy Living/WellnessDepression among diabetics linked to higher risk of kidney diseaseby Tabitha Laffernis
Healthy Living/WellnessTequila ingredient agave could aid weight loss and insulin regulationby Tabitha Laffernis
Healthy Living/WellnessTake that cholesterol pill, statins have minimal side effects: Studyby Rhodilee Jean Dolor
Healthy Living/WellnessWHO wants you to cut down daily sugar intake to 5 percent of total caloriesby Rhodilee Jean Dolor
Healthy Living/WellnessHigh protein diet as bad as smoking for middle-aged peopleby Rhodilee Jean Dolor
Healthy Living/WellnessCalifornia lawmakers want you to read the warning label before you gulp that colaby Randell Suba
Healthy Living/WellnessConsumerism, especially television, computers, and cars are making people in developing countries obese and diabetic, warns new researchby Maryanne Moll
Healthy Living/WellnessInsulin-producing pancreas cells created in diabetic mice: Cure for type 1 diabetes on way?by Alex Saltarin
Healthy Living/WellnessOramed oral insulin capsule clinical trial success may make it world's first insulin pill for diabeticsby Rhodilee Jean Dolor